- Home
- ZENV vs GNTA Comparison
ZENV vs GNTA Comparison
Compare ZENV & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZENV
- GNTA
- Stock Information
- Founded
- ZENV 2005
- GNTA 2014
- Country
- ZENV Brazil
- GNTA Italy
- Employees
- ZENV N/A
- GNTA N/A
- Industry
- ZENV Computer Software: Prepackaged Software
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZENV Technology
- GNTA Health Care
- Exchange
- ZENV Nasdaq
- GNTA Nasdaq
- Market Cap
- ZENV 79.2M
- GNTA 81.2M
- IPO Year
- ZENV 2021
- GNTA 2021
- Fundamental
- Price
- ZENV $1.49
- GNTA N/A
- Analyst Decision
- ZENV
- GNTA Strong Buy
- Analyst Count
- ZENV 0
- GNTA 1
- Target Price
- ZENV N/A
- GNTA $25.00
- AVG Volume (30 Days)
- ZENV 87.2K
- GNTA 29.4K
- Earning Date
- ZENV 07-02-2025
- GNTA 01-01-0001
- Dividend Yield
- ZENV N/A
- GNTA N/A
- EPS Growth
- ZENV N/A
- GNTA N/A
- EPS
- ZENV N/A
- GNTA N/A
- Revenue
- ZENV $181,911,572.00
- GNTA N/A
- Revenue This Year
- ZENV $8.58
- GNTA N/A
- Revenue Next Year
- ZENV $8.83
- GNTA N/A
- P/E Ratio
- ZENV N/A
- GNTA N/A
- Revenue Growth
- ZENV 23.99
- GNTA N/A
- 52 Week Low
- ZENV $1.02
- GNTA $2.74
- 52 Week High
- ZENV $3.03
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- ZENV 44.62
- GNTA 54.55
- Support Level
- ZENV $1.45
- GNTA $2.74
- Resistance Level
- ZENV $1.59
- GNTA $3.94
- Average True Range (ATR)
- ZENV 0.16
- GNTA 0.29
- MACD
- ZENV -0.01
- GNTA 0.08
- Stochastic Oscillator
- ZENV 16.96
- GNTA 88.33
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.